Plasma Level Formaldehyde in Children Receiving Pulpotomy Treatment under General Anesthesia

Objectives: Formocresol has long been used by dentists for pulpotomy of primary teeth. Due to some concerns regarding its possible carcinogenicity, formocresol has been the topic of numerous studies. This study sought to assess the changes in plasma level of formaldehyde of children after receiving pulpotomy under general anesthesia. Study design: Twenty-five children between 2–6 years requiring dental treatments under general anesthesia were studied. Blood samples were taken of children before and after the procedure. Plasma level of formaldehyde was measured using high performance liquid chromatography (HPLC). Results: A total of 106 pulpotomy treatments were performed in 25 children using 126 cotton pellets dipped in formocresol. An increase and a decrease in plasma level of formaldehyde were noted in 5 (20%) and 20 (80%) children, respectively post-operatively compared to baseline. The t-test showed no significant difference in plasma level of formaldehyde pre- and postoperatively (P=0.12). the plasma level of formaldehyde in children who had higher levels of formaldehyde prior to the operation was also higher than that of others after the operation and this association was statistically significant (P=0.001, r=0.64). Conclusions: The results showed no significant change in the mean plasma level of formaldehyde in children who received pulpotomy under general anesthesia compared to its baseline value.

Formaldehyde; Pulpotomy; Primary teeth; Chromatography

1. Hunter M, Hunter B. Vital pulpotomy in the primary dentition: attitudes and practices of specialists in paediatric dentistry practising in the United Kingdom. Int J Paedriatr Dent;13(4):246-50. 2003.

2. Chandrashekhar S, Shashidhar J. Formocresol, still a controversial material for pulpotomy: A critical literature review. J Res Dent;2(3):114. 2014.

3. Schwartz E. Formocresol vital pulpotomy on permanent dentition. Journal (Canadian Dental Association);46(9):570. 1980.

4. Buckley JP. The chemistry of pulp decomposition, with a rational treatment for this condition and its sequelae. Amer Dent J;3:764-71. 1904.

5. Ranly DM, Fulton R. Reaction of rat molar pulp tissue to formocresol, formaldehyde, and cresol. J Endod;2(6):176-81. 1976.

6. Pashley EL, Myers DR, Pashley DH, Whitford GM. Systemic distribution of 14C-formaldehyde from formocresol-treated pulpotomy sites. J Dent Res;59(3):602-7. 1980.

7. Organization WH. Formaldehyde: environmental health criteria 89, Inter-national Programme on Chemical Safety, Geneva, 1989. 2006.

8. Frisbie SH, Mitchell EJ, Dustin H, Maynard DM, Sarkar B. World Health Organization discontinues its drinking-water guideline for manganese. Environ Health Prespect;120(6):775. 2012.

9. Owen B, Dudney C, Tan E, Easterly C. Formaldehyde in drinking water: comparative hazard evaluation and an approach to regulation. Regul Toxicol Pharmacol;11(3):220-36. 1990.

10. Organization WH. Guidelines for drinking-water quality: recommenda-tions: World Health Organization; 2004.

11. Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst;95(21):1615-23. 2003.

12. Topping M. Occupational exposure limits for chemicals. Occup Environ Med;58(2):138-44. 2001.

13. für Risikobewertung B, Schulte HvA, Bernauer U, Madle S, Mielke H, Herbst U, et al. Assessment of the Carcinogenicity of Formaldehyde [CAS No. 50-00-0]. BfR-Hausdruckerei Dahlem, Berlin, S.1-150. 2006.

14. Lewis B. The obsolescence of formocresol. Br Dent J;207(11):525-8. 2009.

15. Leite ACGL, Rosenblatt A, da Silva Calixto M, da Silva CM, Santos N. Genotoxic effect of formocresol pulp therapy of deciduous teeth. Mutat Res-Gen Tox En;747(1):93-7. 2012.

16. Hileman B. Formaldehyde: assessing the risk. Environ Sci Technol;18(7). 1984.

17. Wang Y-S, Tan X, Xue J-H, Li G-R, Shi L-F, Yang H-M, et al. Determi-nation of trace formaldehyde in blood plasma by resonance fluorescence technology. Analytica chimica acta;690(2):234-9. 2011.

18. Johannsen FR, Levinskas GJ, Tegeris AS. Effects of formaldehyde in the rat and dog following oral exposure. Toxicol Lett;30(1):1-6. 1986.

19. HECK HdA, CASANOVA-SCHM1TZ M, Dodd PB, Schachter EN, Witek TJ, Tosun T. Formaldehyde (CH2O) concentrations in the blood of humans and Fischer-344 rats exposed to CH2O under controlled conditions. Am Ind Hyg Assoc J;46(1):1-3. 1985.

20. Amelio I, Cutruzzola F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. Trends Biochem Sci;39(4):191-8. 2014.

21. Humans IWGotEoCRt. Formaldehyde, 2-butoxyethanol and 1-tert-butoxy-propan-2-ol. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer;88:1. 2006.

22. Block RM, Lewis RD, Sheats JB, Burke SG. Antibody formation to dog pulp tissue altered by formocresol within the root canal. Oral Surg Oral Med Oral Pathol;45(2):282-92. 1978.

23. Lewis B. The obsolescence of formocresol. J Calif Dent Assoc;38(2):102-7. 2010.

24. Lewis BB, Chestner SB. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. J Am Dent Assoc;103(3):429-34. 1981.

25. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, et al. IPCS guidelines for the monitoring of genotoxic effects of carcino-gens in humans. Mutat Res-Gen Tox En;463(2):111-72. 2000.

26. Duronio P. Formaldehyde in Dentistry: The Irrational Fear of a Human Endogenous Substance.

27. Merk O, Speit G. Significance of formaldehyde‐induced DNA–protein crosslinks for mutagenesis. Environ Mol Mutagen;32(3):260-8. 1998.

28. Schmid O, Speit G. Genotoxic effects induced by formaldehyde in human blood and implications for the interpretation of biomonitoring studies. Mutagenesis;22(1):69-74. 2006.

29. Cogliano VJ, Grosse Y, Baan RA, Straif K, Secretan MB, El Ghissassi F, et al. Meeting report: summary of IARC monographs on formalde-hyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol. Environ Health Perspect;1205-8. 2005.

30. Health UDo, Services H. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Asbestos Update Agency for Toxic Substances and Disease Registry. 1999.

31. Squire RA, Cameron LL. An analysis of potential carcinogenic risk from formaldehyde. Regul Toxicol Pharmacol;4(2):107-29. 1984.

32. Yoon RK, Chussid S, Davis MJ, Bruckman KC. Preferred treatment methods for primary tooth vital pulpotomies. N Y State Dent J;74(2):47. 2008.

33. Casanova-Schmitz M, Starr TB, Heck HdA. Differentiation between meta-bolic incorporation and covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by inhaled [14C]-and [3H] form-aldehyde. Toxicol Appl Pharmacol;76(1):26-44. 1984.

34. Casanova-Schmitz M, David RM, Heck HdA. Oxidation of formalde-hyde and acetaldehyde by NAD+-dependent dehydrogenases in rat nasal mucosal homogenates. Biochem Pharmacol;33(7):1137-42. 1984.

35. Kahl J, Easton J, Johnson G, Zuk J, Wilson S, Galinkin J. Formocresol blood levels in children receiving dental treatment under general anes-thesia. Pediatr Dent;30(5):393-9. 2008.

36. Luo W, Li H, Zhang Y, Ang CY. Determination of formaldehyde in blood plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl J;753(2):253-7. 2001.

37. Zarzar P, Rosenblatt A, Takahashi C, Takeuchi P, Júnior LC. Formocresol mutagenicity following primary tooth pulp therapy: an in vivo study. J Dent;31(7):479-85. 2003.

38. Da Silva GN, De Camargo EA, Salvadori DM, Ribeiro DA. Genetic damage in human peripheral lymphocytes exposed to antimicrobial endodontic agents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod;104(2):e58-e61. 2007.

39. Milnes AR. Is formocresol obsolete? A fresh look at the evidence concerning safety issues. J Endod;34(7):S40-S6. 2008.

40. Myers DR, Shoaf HK, Dirksen TR, Pashley DH, Whitford GM, Reynolds KE. Distribution of 14 C-formaldehyde after pulpotomy with formocresol. J Am Dent Assoc;96(5):805-13. 1978.

41. Myers D, Pashley DH, Whitford GM, Sobel R, McKinney R. The acute toxicity of high doses of systemically administered formocresol in dogs. Pediatr Dent;3(1):37. 1981.

42. Gahyva SMM, Siqueira Junior JF. Direct genotoxicity and mutagenicity of endodontic substances and materials as evaluated by two prokaryotic test systems. J Appl Oral Sci;13(4):387-92. 2005.

43. Kabaktchieva R. Comparative cytotoxicity evaluation of medicines used for pulptherapy of primary teeth. J of IMAB;18(2):200-10. 2012.

44. Cancer IAfRo. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypro-pan-2-ol: World Health Organization; 2006.

45. Helmuth R, Hensel A. Management recommendations of the Federal Institute for Risk Assessment (BfR) after the international BfR symposium “Towards a Risk Analysis of Antibiotic Resistance”. Int JMed Micro-biol;296:15-7. 2006.

46. Schroeter JD, Campbell J, Kimbell JS, Conolly RB, Clewell HJ, Andersen ME. Effects of endogenous formaldehyde in nasal tissues on inhaled formaldehyde dosimetry predictions in the rat, monkey, and human nasal passages. Toxicol Sci;138(2):412-24. 2014.

47. Rousseau M-C, Straif K, Siemiatycki J. IARC carcinogen update. Environ health perspect;113(9):A580. 2005.

48. Conolly RB, Kimbell JS, Janszen D, Schlosser PM, Kalisak D, Preston J, et al. Human respiratory tract cancer risks of inhaled formaldehyde: dose-re-sponse predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol Sci;82(1):279- 96. 2004.

49. Liteplo R, Meek M. Inhaled formaldehyde: exposure estimation, hazard characterization, and exposure-response analysis. J Toxicol Environ Health B;6(1):85-114. 2003.

50. Markovic D, Zivojinovic V, Vucetic M. Evaluation of three pulpotomy medicaments in primary teeth. Eur J Paediatr Dent;6(3):133. 2005.

51. Davis M, Myers R, Switkes M. Glutaraldehyde: an alternative to formo-cresol for vital pulp therapy. ASDC J Dent Child;49(3):176-80. 1981.

52. Olatosi OO, Sote EO, Orenuga OO. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radio-graphic study. Niger J Clin Pract;18(2):292-6. 2015.

53. Shulman ER, Mciver FT, Burkes Jr EJ. Comparison of electrosurgery and formocresol as pulpotomy techniques in monkey primary teeth. Pediatr Dent;9(3):189-94. 1987.

54. Stringhini Junior E, Vitcel ME, Oliveira LB. Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol. Eur Arch Paediatr Dent;16(4):303-12. 2015.

55. Havale R, Anegundi RT, Indushekar K, Sudha P. Clinical and radiographic evaluation of pulpotomies in primary molars with formocresol, glutaralde-hyde and ferric sulphate. Oral Health Dent Manag;12(1):24-31. 2013.